Our molecular analyses (showing that HORMAD1 promotes HR in lung adenocarcinoma cell lines) mechanistically explain a recent report by Wang et al. showing that HORMAD1 confers resistance to PARP inhibitors45. This evidence concerns the gene HORMAD1 and lung adenocarcinoma.